Page last updated: 2024-08-16

propachlor and everolimus

propachlor has been researched along with everolimus in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhuta, S; Damoiseaux, R; Ding, B; Hsia, E; Huang, J; Liang, C; Liu, N; Sun, Y; Tai, S; Thor, RK	1

Other Studies

1 other study(ies) available for propachlor and everolimus

Article	Year
Combination of Rad001 (everolimus) and propachlor synergistically induces apoptosis through enhanced autophagy in prostate cancer cells. Molecular cancer therapeutics, 2012, Volume: 11, Issue:6 Topics: Acetanilides; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 12; Autophagy-Related Protein 5; Beclin-1; Cell Line, Tumor; Drug Synergism; Everolimus; Humans; Male; Membrane Proteins; Mice; Mice, SCID; Microtubule-Associated Proteins; Prostatic Neoplasms; Sirolimus; Small Ubiquitin-Related Modifier Proteins	2012

Article

Year

Combination of Rad001 (everolimus) and propachlor synergistically induces apoptosis through enhanced autophagy in prostate cancer cells.

Molecular cancer therapeutics, 2012, Volume: 11, Issue:6

Topics: Acetanilides; Animals; Antineoplastic Agents; Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Protein 12; Autophagy-Related Protein 5; Beclin-1; Cell Line, Tumor; Drug Synergism; Everolimus; Humans; Male; Membrane Proteins; Mice; Mice, SCID; Microtubule-Associated Proteins; Prostatic Neoplasms; Sirolimus; Small Ubiquitin-Related Modifier Proteins

2012